Pharmaceutical Technology

SEPTEMBER 7, 2022

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Leads 52

Leads Pharmaceutical Patients Pharmaceutical manufacturing 52

PM360

OCTOBER 8, 2024

The company is the only pure-bred pharmacovigilance specialist, providing comprehensive, independent pharmacovigilance services as well as advanced tools and technology-powered solutions that address companies’ most complex product safety needs. It was a great honor to be approached to lead Qinecsa’s next important growth phase.

Leads 52

Leads Safety Biopharma Management 52

eMediWrite

NOVEMBER 22, 2024

Deeply Understand Your Market and Audience To create a leading product, you need to understand the therapeutic area thoroughly. Equally important is understanding your target audience—patients, healthcare professionals, regulators, and payers. It could be superior efficacy, a better safety profile, or more affordable pricing.

52

52

World of DTC Marketing

MARCH 23, 2022

Accelerated Approval allows for early access to drugs and biologics based on initial evidence of safety and effectiveness, while confirmatory studies required to verify clinical benefits are ongoing. Do patients care? The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012.

Patients 200

Patients FDA Doctors Physicians 200

Contrarian Sales Techniques

NOVEMBER 21, 2024

From explaining how a medication works to addressing patient concerns, reps play a vital role in bridging the gap between healthcare providers and patients. The Role of Medical Reps in Patient Education Patient education isn’t just about handing out brochures. What is Evidence-Based Medicine?

Education 52

Education Medical Patients Doctors 52

European Pharmaceutical Review

OCTOBER 20, 2022

Apogenix , a biopharmaceutical company developing next generation immunotherapeutics, announced that asunercept showed statistically significant benefits for hospitalised COVID-19 patients in the ASUNCTIS trial. The Phase II trial investigated efficacy and safety of asunercept in 435 patients with moderate to severe COVID-19 disease.

Patients 105

Patients Safety Medicine Leads 105

European Pharmaceutical Review

DECEMBER 18, 2023

After eight weeks of treatment, patients’ depression severity scores dropped by an average of 19.1 As an oncologist for many years, I experienced the frustration of not being able to provide cancer care that treats the whole person, not just the tumour,” commented Manish Agrawal, MD, of Sunstone Therapies and lead author of the study.

Food and Drug Administration 116

Food and Drug Administration Patients Side effects Safety 116

Referral MD

OCTOBER 7, 2024

Securing Patient Portals: Best Practices for Protecting Online Records 33.33% of patient portals have privacy concerns that create a sense of distrust among many providers and patients. Implement 1-2 strategies below to better comply with privacy regulations and protect your patients against breaches.

Patients 96

Patients Healthcare Healthcare Healthcare Provider 96

Healthcare Success

MAY 9, 2022

The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .

Leads 52

Leads Patients Healthcare Provider Healthcare 52

European Pharmaceutical Review

JUNE 29, 2022

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. This could lead to false positives or, even worse, false negatives!

Ethics 98

Ethics Safety Manufacturing Medicine 98

pharmaphorum

OCTOBER 14, 2022

Devices such as smart pill boxes, electronic blood collection devices, wearable monitors, and intelligent labels are increasingly being used to improve healthcare efficiency and conditions for patients, but present an “expanding e-waste challenge.” Photo by Possessed Photography on Unsplash.

Leads 123

Leads Electronics Ethics Healthcare 123

European Pharmaceutical Review

SEPTEMBER 22, 2022

EBT-101, a CRISPR-Cas9 gene editing system delivered by adenovirus-associated virus vector serotype 9 (AAV9) has been administered to the first individual in a Phase I/II trial designed to establish its safety and efficacy. As a result, HIV can persist in tissue reservoirs for years.

Patients 145

Patients Safety Medicine Physicians 145

European Pharmaceutical Review

JANUARY 17, 2023

A Phase IIa pilot trial of CER-001 showed for the first time in a human pilot trial, that recovery of a normal protein apolipoprotein A-I (apoA-I) level in patients stop the cytokine storm and improve clinical outcomes. CER-001 is the only natural recombinant apoA-I for septic patients at high risk of acute kidney injury (AKI).

Patients 98

Patients Safety Pharma Medicine 98

Impetus Digital

JANUARY 30, 2023

Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.

Pharmaceutical 68

Pharmaceutical Patients Safety Medical 68

MedCity News

JUNE 30, 2022

The FDA placed a partial clinical hold on late-stage tests of Sanofi multiple sclerosis drug tolebrutinib after some patients developed drug-induced liver injury. tests are paused, Sanofi said clinical testing in other countries is continuing with additional safety monitoring.

FDA 97

FDA Leads Safety Patients 97

MedCity News

OCTOBER 16, 2023

Called Microsoft Fabric, which was rolled out broadly in May, the announcement on October 10 marks the availability of Fabric’s capabilities specifically for the healthcare vertical – to clinicians, administrators but perhaps, most importantly, to patients. Lungs hyperinflated to clear. No pneumothorax or pleural eltusion.

Healthcare 119

Healthcare Healthcare Patients Doctors 119

Healthcare Success

AUGUST 19, 2024

Plus, 20% of patients prefer receiving health information via text message, according to the HIPAA Journal. Discover strategic and emerging applications in SMS marketing, and best practices that can help simplify your organization’s workload and streamline patient communications. But it can do so much more.

Healthcare 70

Healthcare Healthcare Marketing Patients 70

European Pharmaceutical Review

JUNE 13, 2024

Tell us about Ocugen’s lead programme, OCU400. Ocugen plans to expand the OCU400 clinical trial in the second half of 2024 to include patients with LCA, contingent on favourable results from the Phase I/II study and alignment with regulatory agencies. What’s the latest and what’s next?

Manufacturing 145

Manufacturing Food and Drug Administration Engineering Safety 145

PM360

NOVEMBER 27, 2023

Up to now, drug safety teams have relied primarily on reactive reporting systems for pharmacovigilance (PV) or real-world drug safety monitoring. Proactive signal detection aims to transform PV by harnessing the power of real-world data (RWD) and cutting-edge analytics to stay ahead of potential safety issues.

Safety 106

Safety Electronics Patients Physicians 106

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

European Pharmaceutical Review

AUGUST 18, 2022

The US Food and Drug Administration (FDA) has approved bluebird bio’s Zynteglo (betibeglogene autotemcel; beti-cel), the first cell-based gene therapy for the treatment of adult and paediatric patients with beta-thalassemia who require regular red blood cell transfusions. .

Food and Drug Administration 98

Food and Drug Administration Patients FDA Food 98

European Pharmaceutical Review

OCTOBER 20, 2022

City of Hope , one of the largest cancer research and treatment organisations in the US, announced that the first patient to receive novel cancer medicine AOH1996, is doing well. Eligible patients include adults with solid tumours who have not found standard treatments effective.

Patients 98

Patients Medicine Medical Safety 98

pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Patient choice will push sponsors toward operational excellence.

Safety 109

Safety Management Patients Training 109

Referral MD

OCTOBER 12, 2023

Photo by Luis Melendez on Unsplash Improving patient engagement has recently become a top priority in the healthcare sector. This shift has been driven by the realization that involving patients in their care can lead to better health outcomes and increased satisfaction.

Patients 52

Patients Healthcare Provider Healthcare Healthcare 52

European Pharmaceutical Review

OCTOBER 21, 2022

Clinical trial results presented at the US IDWeek conference, revealed a three-dose series of the HEPLISAV-B vaccine prevents hepatitis B virus (HBV) in HIV patients not previously vaccinated against or infected with the virus. At week 28, the study assessed the vaccine’s safety and levels of anti-HBV surface antibodies (HBsAbs).

Patients 96

Patients Food and Drug Administration Side effects Food 96

Pharmaceutical Technology

SEPTEMBER 6, 2022

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

Pharmaceutical 59

Pharmaceutical Leads Pharma Transportation 59

pharmaphorum

DECEMBER 1, 2022

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Patients 108

Patients Transportation Retail Recruitment 108

eMediWrite

JULY 13, 2023

They play a crucial role in assuring the efficacy and safety of products given to patients. Since any inaccuracies might lead to the production of goods that might be ineffective or endanger human safety, it is understandable that regulatory oversight of QC Authority data is rigorous.

Pharmaceutical products 52

Pharmaceutical products Safety Pharmaceutical Pharmaceutical manufacturing 52

Pharma Marketing Network

SEPTEMBER 15, 2021

Maximizing Patient Safety and Sustaining Long Term Quality Through Enhanced Device Surveillance while navigating the EU Regulatory Landscape. The post EU Medical Device Safety Monitoring & Reporting Conference | October 26-28, 2021 | Berlin, Germany and Virtual appeared first on Pharma Marketing Network. REGISTER TODAY.

Safety 52

Safety Medical Digital Media Marketing 52

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Patients 100

Patients Pharmaceutical Medical Physicians 100

MedCity News

APRIL 10, 2023

Greater collaboration among healthcare providers, medical device manufacturers, and lawmakers and regulators will lead to predictability and consistency in cybersecurity management. Together, we can make even greater strides toward patient safety and a more secure and sustainable healthcare system.

Manufacturing 94

Manufacturing Medical Healthcare Provider Safety 94

European Pharmaceutical Review

FEBRUARY 27, 2024

Leading the MHRA – a five year journey Professor Graham Cooke, interim chair of the MHRA board, remarked that Dame June’s “leadership of the MHRA over the last five years, particularly during the COVID-19 pandemic, has been exceptional.” Her previous role in the agency was as Director of Vigilance and Risk Management of Medicines.

Safety 111

Safety Pharmacology Medicine Education 111

Pharmaceutical Technology

JUNE 8, 2023

The use of 4D Molecular Therapeutics’ (4DMT) aerosolised gene therapy 4D-710 has improved the quality-of-life and spirometry-measured outcomes in three cystic fibrosis patients , based on early results from a Phase I/II study presented at this year’s annual meeting of the European Cystic Fibrosis Society (ECFS).

Patients 98

Patients Food and Drug Administration Food Safety 98

European Pharmaceutical Review

OCTOBER 20, 2023

In a long-term extension study, Eli Lilly and Company’s biologic lebrikizumab enabled almost 80 percent of patients with moderate-to-severe atopic dermatitis (eczema), who continued monthly maintenance dosing for up to two years, to maintain fully or almost complete skin clearance for this period.

Safety 105

Safety Pharmaceutical Patients Medicine 105

Clarivate

NOVEMBER 13, 2023

Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and payers. A clinical outcome assessment is a measure that describes or reflects how a patient feels, functions or survives.

Patients 52

Patients Food and Drug Administration FDA Safety 52

European Pharmaceutical Review

OCTOBER 22, 2024

The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patient care, says the Medicines and Healthcare products Regulatory Agency (MHRA). Demand for delivery of care by hospitals will also be eased with implementation of the regulation. [The

Medicine 52

Medicine Manufacturing Safety Consulting 52

European Pharmaceutical Review

APRIL 17, 2024

Roche’s twice-yearly, 10-minute subcutaneous injection of OCREVUS ® (ocrelizumab) has shown significant promise for patients with either with relapsing or primary progressive multiple sclerosis (RMS or PPMS). percent had no relapse) in patients through 48 weeks of the treatment. No new safety signals were identified for OCREVUS SC.

Food and Drug Administration 93

Food and Drug Administration Safety Medicine Food 93